Literature DB >> 9149642

Evaluation and management of diabetes insipidus.

P Adam1.   

Abstract

Diabetes insipidus is an uncommon condition characterized by polyuria and polydipsia. The symptoms and biochemical changes of this condition result from either a lack of antidiuretic hormone or renal insensitivity to its effect. Failure to produce or release antidiuretic hormone may result from cranial pathology, including trauma and surgery. The renal insensitivity to antidiuretic hormone that occurs in patients with nephrogenic diabetes insipidus may be caused by genetic factors, drugs (especially lithium) or specific disease processes. Patients may compensate for polyuria and nocturia by excessive water intake but show marked decreases in urine specific gravity and osmolality. Patients with severe and uncompensated symptoms develop marked dehydration, neurologic symptoms and encephalopathy. The water deprivation test is useful in diagnosing diabetes insipidus and in differentiating neurogenic from nephrogenic cases. Neurogenic diabetes insipidus may respond to nasal administration of desmopressin. Nephrogenic diabetes insipidus requires good hydration and monitoring of body chemistry. Thiazides and amiloride may relieve symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9149642

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  Nocturia.

Authors:  Mark S Soloway; Jeffrey P Weiss; Alan J Wein
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

2.  Multiple fractures and impaired bone metabolism in Wolfram syndrome: a case report.

Authors:  Antonino Catalano; Federica Bellone; Giuseppe Cicala; Annalisa Giandalia; Nunziata Morabito; Domenico Cucinotta; Giuseppina Tiziana Russo
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

3.  EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption.

Authors:  Pui W Cheung; Naohiro Nomura; Anil V Nair; Nutthapoom Pathomthongtaweechai; Lars Ueberdiek; Hua A Jenny Lu; Dennis Brown; Richard Bouley
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

Review 4.  Adverse endocrine and metabolic effects of psychotropic drugs: selective clinical review.

Authors:  Chaya G Bhuvaneswar; Ross J Baldessarini; Veronica L Harsh; Jonathan E Alpert
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

Review 5.  Nocturia.

Authors:  Jeffrey P Weiss; Jerry G Blaivas
Journal:  Curr Urol Rep       Date:  2003-10       Impact factor: 2.862

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.